The Role of Probiotics and Their Metabolites in the Treatment of Depression
Molecules · 2023
DOI: 10.3390/molecules28073213 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Monika Elżbieta Jach und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, The John Paul II Catholic University of Lublin, Konstantynów Street 1I, 20-708 Lublin, Poland. Hauptthemen laut MEDLINE: Major Depressive Disorder, Probiotics, Gastrointestinal Microbiome. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Depression is a common and complex mental and emotional disorder that causes disability, morbidity, and quite often mortality around the world. Depression is closely related to several physical and metabolic conditions causing metabolic depression. Studies have indicated that there is a relationship between the intestinal microbiota and the brain, known as the gut–brain axis. While this microbiota–gut–brain connection is disturbed, dysfunctions of the brain, immune system, endocrine system, and gastrointestinal tract occur. Numerous studies show that intestinal dysbiosis characterized by abnormal microbiota and dysfunction of the microbiota–gut–brain axis could be a direct cause of mental and emotional disorders. Traditional treatment of depression includes psychotherapy and pharmacotherapy, and it mainly targets the brain. However, restoration of the intestinal microbiota and functions of the gut–brain axis via using probiotics, their metabolites, prebiotics, and healthy diet may alleviate depressive symptoms. Administration of probiotics labeled as psychobiotics and their metabolites as metabiotics, especially as an adjuvant to antidepressants, improves mental disorders. It is a new approach to the prevention, management, and treatment of mental and emotional illnesses, particularly major depressive disorder and metabolic depression. For the effectiveness of antidepressant therapy, psychobiotics should be administered at a dose higher than 1 billion CFU/day for at least 8 weeks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, The John Paul II Catholic University of Lublin, Konstantynów Street 1I, 20-708 Lublin, Poland.
- Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Lublin, Chodźki Street 1, 20-093 Lublin, Poland.
- Department of Biomedicine and Environmental Research, The John Paul II Catholic University of Lublin, Konstantynów Street 1J, 20-708 Lublin, Poland.
- Department of Animal and Rural Technology, State University of Southwest Bahia, Itapetinga 45700-000, BA, Brazil.
- Independent Unit of Experimental Neuropathophysiology, Department of Toxicology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.
- Department of Natural Products Chemistry, Medical University of Lublin, Chodźki Street 1, 20-093 Lublin, Poland.
ORCID-Profile: Monika Elżbieta Jach, Anna Serefko, Aleksandra Szopa, Ewa Sajnaga, Hieronim Golczyk, Kinga Borowicz-Reutt, Elwira Sieniawska
Zitieren
APA
Jach, M. E., Serefko, A., Szopa, A., Sajnaga, E., Golczyk, H., Santos, L. S., Borowicz-Reutt, K., & Sieniawska, E. (2023). The Role of Probiotics and Their Metabolites in the Treatment of Depression. Molecules. https://doi.org/10.3390/molecules28073213
Vancouver
Jach ME, Serefko A, Szopa A, Sajnaga E, Golczyk H, Santos LS, et al. The Role of Probiotics and Their Metabolites in the Treatment of Depression. Molecules. 2023. doi:10.3390/molecules28073213
BibTeX
@article{Jach2023,
author = {Jach, Monika Elżbieta and Serefko, Anna and Szopa, Aleksandra and Sajnaga, Ewa and Golczyk, Hieronim and Santos, Leandro Soares and Borowicz-Reutt, Kinga and Sieniawska, Elwira},
title = {The Role of Probiotics and Their Metabolites in the Treatment of Depression},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28073213}
}
EUVIMED